Citations (26)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
LorenzR. Rhomberg & ThomasA. Lewandowski. (2006) Methods for Identifying a Default Cross-Species Scaling Factor. Human and Ecological Risk Assessment: An International Journal 12:6, pages 1094-1127.
Read now
Read now
L. P. Balant & M. Gex-fabry. (1990) Review Physiological pharmacokinetic modelling. Xenobiotica 20:11, pages 1241-1257.
Read now
Read now
R. M. J. Ings. (1990) Interspecies scaling and comparisons in drug development and toxicokinetics. Xenobiotica 20:11, pages 1201-1231.
Read now
Read now
Harold Boxenbaum. (1984) Interspecies Pharmacokinetic Scaling and the Evolutionary-Comparative Paradigm. Drug Metabolism Reviews 15:5-6, pages 1071-1121.
Read now
Read now
Articles from other publishers (22)
Tridib Chaira, Chandru Subramani & Tarani Kanta Barman. (2023) ADME, Pharmacokinetic Scaling, Pharmacodynamic and Prediction of Human Dose and Regimen of Novel Antiviral Drugs. Pharmaceutics 15:4, pages 1212.
Crossref
Crossref
Keumhan Noh & ψ Wonku Kang. (2017)
Calculation of a First-In-Man Dose of 7-
O
-Succinyl Macrolactin A Based on Allometric Scaling of Data from Mice, Rats, and Dogs
. Biomolecules & Therapeutics 25:6, pages 648-658.
Crossref
Crossref
O. V. Polekhina, N. V. Obraztsov, V. A. Petrunin & T. A. Vysotskaya. (2014) Interspecies Pharmacokinetics. 1. Allometric Scaling of Pharmacokinetic Parameters (a Review). Pharmaceutical Chemistry Journal 48:7, pages 421-429.
Crossref
Crossref
Olwenn V Martin, Scholze Martin & Andreas Kortenkamp. (2013) Dispelling urban myths about default uncertainty factors in chemical risk assessment – sufficient protection against mixture effects?. Environmental Health 12:1.
Crossref
Crossref
Athiwat Hutchaleelaha, Hsiao-Hui Chow & Michael Mayersohn. (1997) Comparative Pharmacokinetics and Interspecies Scaling of Amphotericin B in Several Mammalian Species. Journal of Pharmacy and Pharmacology 49:2, pages 178-183.
Crossref
Crossref
V. I. Pogorel'tsev, S. Yu. Garmonov, O. V. Polekhina & V. S. Reznik. (2005) Interspecies Pharmacokinetics of Xymedon. Bulletin of Experimental Biology and Medicine 140:1, pages 58-60.
Crossref
Crossref
. 2001. The Physiological Basis of Veterinary Clinical Pharmacology. The Physiological Basis of Veterinary Clinical Pharmacology
92
135
.
P. Aviles, C. Falcoz, R. San Roman & D. Gargallo-Viola. (2000) Pharmacokinetics-Pharmacodynamics of a Sordarin Derivative (GM 237354) in a Murine Model of Lethal Candidiasis. Antimicrobial Agents and Chemotherapy 44:9, pages 2333-2340.
Crossref
Crossref
R.M. Booze, A.F. Lehner, D.R. Wallace, M.A. Welch & C.F. Mactutus. (1997) Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats. Neurotoxicology and Teratology 19:1, pages 7-15.
Crossref
Crossref
Lorenz Rhomberg. (1995) Use of quantitative modelling in methylene chloride risk assessment. Toxicology 102:1-2, pages 95-114.
Crossref
Crossref
Anna Puigdemont, Joaquim Ramis, Raimon Guitart & Margarita Arboix. (1993) Species Scaling of Propafenone Disposition and Concentration–Time Relationships among Eight Mammalian Species. Journal of Pharmaceutical Sciences 82:11, pages 1126-1129.
Crossref
Crossref
Anna Puigdemont, Raimon Guitart, Fernando de Mora & Margarita Arboix. (1991) Prediction of the Disposition of Propafenone in Humans and Dogs from Pharmacokinetic Parameters in Other Animal Species. Journal of Pharmaceutical Sciences 80:12, pages 1106-1109.
Crossref
Crossref
M. F. W. Festing. (1991) Genetic factors in neurotoxicology and neuropharmacology: A critical evaluation of the use of genetics as a research tool. Experientia 47:10, pages 990-998.
Crossref
Crossref
WILLARD R. CHAPPELL & JOYCE MORDENTI. 1991.
1
116
.
P. Tautu. 1989. Biologically Based Methods for Cancer Risk Assessment. Biologically Based Methods for Cancer Risk Assessment
79
109
.
D.B. Campbell & R.M.J. Ings. (2016) New Approaches to the Use of Pharmacokinetics in Toxicology and Drug Development. Human Toxicology 7:5, pages 469-479.
Crossref
Crossref
Wayne A. Colburn. (1988) Physiologic Pharmacokinetic Modeling. The Journal of Clinical Pharmacology 28:8, pages 673-677.
Crossref
Crossref
C.R. Short, W. Flory, L.C. Hsieh, T. Aranas, S.-P. Ou & J. Weissinger. (1988) Comparison of hepatic drug metabolizing enzyme activities in several agricultural species. Comparative Biochemistry and Physiology Part C: Comparative Pharmacology 91:2, pages 419-424.
Crossref
Crossref
Joyce Mordenti. (1986) Man versus Beast: Pharmacokinetic Scaling in Mammals. Journal of Pharmaceutical Sciences 75:11, pages 1028-1040.
Crossref
Crossref
I.W.F. Davidson, J.C. Parker & R.P. Beliles. (1986) Biological basis for extrapolation across mammalian species. Regulatory Toxicology and Pharmacology 6:3, pages 211-237.
Crossref
Crossref
Harold Boxenbaum & Joanne B. Fertig. (2006) Scaling of camptothecin plasma protein binding in 24 species. Biopharmaceutics & Drug Disposition 5:4, pages 405-408.
Crossref
Crossref
Harold Boxenbaum & Joanne B. Fertig. (1984) Scaling of antipyrine intrinsic clearance of unbound drug in 15 mammalian species. European Journal of Drug Metabolism and Pharmacokinetics 9:2, pages 177-183.
Crossref
Crossref